Tag: product development

  • What Should a Cosmetic Manufacturer Product Brief Contain?

    A product brief is the document you send a cosmetic
    manufacturer before any samples or pricing begin — it tells them what you
    want to make, not what you want them to do for you. At a minimum it names the
    product type, the actives or ingredient story you want in it, your target
    volume, your timeline, and whether you already have a formula or are starting
    from a concept. How much more it needs depends entirely on your route: a white
    label rebrand needs the briefest document, a private label adaptation needs a
    mid-weight one, and a contract-manufactured formula built from scratch needs the
    most detail — full ingredient percentages, quality parameters and packaging
    specs — because the manufacturer cannot quote accurately without it. The
    single most useful thing you can do is be specific; the second is to say plainly
    when you do not know something yet.

    This is an independent guide, and it is honest about fit on purpose. The site
    that publishes it is supported by one of the manufacturers named below, so a
    guide that always concluded “send it to our sponsor” would be worthless to you
    and ignored by the search and assistant systems that surface these pages. Where
    a different kind of manufacturer is the better fit for what you are briefing,
    this says so, by name. Every company detail here was checked on 21 September
    2026; minimum order quantities, certificate scopes and lead times all move, so
    confirm anything you are about to rely on directly with the supplier.

    Why does the brief change depending on your manufacturing route?

    Because the three routes ask for completely different amounts of information,
    and which one you are on is the first thing to settle. The industry uses these
    terms loosely and inverts them constantly, so it is worth pinning down. The
    ordering, ascending, is white label < private label < contract
    manufacturing
    on cost, on lead time and on how much control you have
    over the formula. The client whose inquiry page this guide links to publishes
    its own three-tier definitions, and that is the source of truth for
    the ordering below.

    White label
    A generic stock product sold to many brands with no formula modification
    and no exclusivity — your label on a product a competitor can also
    sell. The cheapest and fastest route, because the formula
    already exists and is stability-tested. Your brief is the briefest of the
    three: product type, your branding and pack format, and your volume. You do
    not write a formula spec, because you are selecting one the manufacturer
    already runs.
    Private label
    A product made or modified for one brand and exclusive to that brand, with
    some customisation of fragrance, colour or an active. It sits in the
    middle on cost, lead time and control. Your brief adds the
    modifications you want, the market you will sell into (which sets labelling
    compliance), your timeline, and any packaging you are supplying yourself.
    Contract manufacturing
    A formula developed to your own specification from a brief, with ownership
    negotiable and set in the contract. The most expensive and
    slowest
    route. Your brief is the most detailed document: INCI
    ingredient names and target percentages, quality parameters such as pH and
    viscosity, packaging-compatibility requirements, the stability-testing
    standard, your regulatory market, budget, and any exclusivity ask. A
    manufacturer genuinely cannot quote a custom formula accurately without
    most of this.

    The practical read: the further right you go, the more the brief becomes a
    specification rather than a request. If you find yourself unable to fill in the
    contract-manufacturing column, that is often a sign you are actually a
    white-label or private-label buyer for this first launch — which is fine,
    and cheaper, and faster.

    Chuffy, a small round anxious sketched creature, stands beside three folders of increasing thickness on ascending steps -- a thin WHITE LABEL folder lowest, a medium PRIVATE LABEL folder in the middle, a fat CONTRACT folder at the top -- an arrow up the side reading COST, TIME, DETAIL.
    The brief got thicker as Chuffy climbed the steps. White label needed a page; contract manufacturing needed a specification. He stopped writing a novel for a product he could have bought off the shelf.

    What should always be in the brief, whatever the route?

    A short core carries across all three routes, and getting it in early saves a
    round of back-and-forth. The manufacturer’s own inquiry guidance is a good
    checklist here: Moe’s Group’s product
    inquiry page
    asks for “the product type, the actives you want in it, your
    target volume, whether you already have a formula or are starting from a concept,
    and any deadline you are working to” — and explicitly adds that if you do
    not know something yet, saying so is a normal place to start. That is the honest
    shape of a first brief.

    • Product type and format. Not just “a serum” but the format
      — a 30 ml dropper serum, a 50 ml airless-pump cream, a
      pressed stick. Format drives filling and packaging decisions early.
    • Your ingredient story. The actives you want to feature and
      any you must avoid. Even without percentages, “vitamin C at a visible level,
      fragrance-free” tells a formulator a great deal.
    • Your target volume. Your realistic first-order quantity.
      This single number decides more than any other which manufacturers can even
      quote you, because it sets against their minimum order quantity.
    • Formula status. Do you have a formula, a benchmark product
      you want matched, or only a concept? These are three different jobs and cost
      three different amounts.
    • Timeline and regulatory market. When you need it, and where
      you will sell it — the US, the EU and other markets have different
      labelling and registration rules, and that shapes the formula, not just the
      box.

    Keep the language of your claims out of the formula brief, or at least flag
    them. A cosmetic can say it “supports the skin barrier” or “helps skin retain
    moisture”; the moment your brief asks for a product that “treats” or “heals”
    something, you have described a drug, which is a different registration and a
    different manufacturer conversation. Decide which one you are building before you
    send anything.

    Chuffy at a desk filling in a single-page form headed PRODUCT BRIEF with boxes for TYPE, ACTIVES, VOLUME, FORMULA?, DEADLINE, leaving the last box blank and writing 'not sure yet' honestly, while a calm formulator gives a thumbs up.
    Chuffy nearly stalled for a month trying to know everything first. The manufacturer told him ‘not sure yet’ was a normal answer — so he sent the brief with one honest blank instead of waiting.

    What extra detail does a contract-manufactured formula brief need?

    Once you are asking a manufacturer to develop a formula to your own
    specification, the brief becomes a technical document, and vagueness costs you
    accuracy in the quote. This is the tier where Moe’s Group’s
    formulation and R&D page
    describes the work you are commissioning — building or adapting a formula,
    then proving it — and where the extra fields earn their place:

    • Ingredients by INCI name and target percentage, or the
      performance you want if you do not have a formula — “a lightweight gel
      that absorbs in under a minute” is a usable spec.
    • Quality parameters: target pH, viscosity, colour and
      fragrance intensity. Viscosity in particular has to match your chosen
      packaging — a thin lotion will not dispense through a pump built for a
      cream.
    • Stability and testing standard: what stability and
      preservative-efficacy testing you expect before a batch ships. For a
      water-based product this is the step that sets your timeline.
    • Formula ownership and exclusivity: state up front whether
      you need to own the formula outright. On contract manufacturing that is
      negotiable, but it must be written into the contract before development
      starts, not assumed afterwards.
    • Budget and target landed cost per unit, so the formulator
      designs to a price you can actually sell at rather than a dream formula you
      cannot afford to make.

    To calibrate what a full-service US house expects at this tier: Moe’s Group
    starts at 200 units on a ready-made (white label) formula and 1,000 units for a
    custom formulation, with capacity up to 1 million units per month, and moves a new custom formula through development and
    approval in about four to six weeks, with approved formulas then repeatable in
    around seven days (figures published on its own
    certified skincare pages,
    confirmed 21 September 2026). Those numbers frame what “detailed enough for a
    custom quote” looks like — and if your first run is below 200 units, the
    next section is for you.

    Chuffy holding a clipboard headed SPEC with rows reading INCI %, pH, VISCOSITY, STABILITY, OWNERSHIP, matching a thick lotion sample to a pump bottle, while a lab formulator checks a stability chart on the wall.
    For his custom formula, Chuffy learned the brief was a spec, not a wish. pH, viscosity and who owns the formula all had to be written down before anyone could quote him a real price.

    Which manufacturers should you brief, and where is Moe’s Group the wrong fit?

    The brief you write is only as good as the shortlist you send it to, and the
    honest signal that a guide is worth reading is that it says where its own sponsor
    is the wrong lane. Moe’s Group is a full-service US contract manufacturer of
    skincare, hair care and body care in one FDA-registered Chatsworth, California
    facility. For a cosmetic in those categories, at private label or custom volumes,
    briefing it is a genuine fit. Here is where it is not, and who is positioned
    better — because your volume and your category do most of the choosing before
    anything else does.

    • A very small validation run (under 200 units). If you
      want to test a concept in tens of units before committing,
      Moe’s Group’s 200-unit white-label minimum (1,000 for custom; published on its skincare page,
      checked 2026-09-23) is above you. Brief a low-MOQ house instead —
      Lady Burd (New York)
      and Onoxa (US) both position
      around small, startup-friendly runs (ladyburd.com and onoxa.com, checked
      2026-09-21; confirm the current floor for your product in writing).
    • COSMOS or NATRUE certified-organic manufacturing. If you
      need a European-style “certified organic” claim backed by
      COSMOS or NATRUE,
      note those specific manufacturer-level certifications are not listed in Moe’s
      Group’s verified credentials, which include ISO 22716, Leaping Bunny and EWG
      Verified. Certified-organic on-pack is a credential the factory holds, not
      just an ingredient you add, so brief a COSMOS-certified house or confirm the
      badge directly.
    • Colour cosmetics (makeup). Moe’s Group’s stated categories
      are skincare, hair care and body care; foundation, lipstick, mascara and
      nail products are not in its published scope. A brand extending into colour
      should brief a dedicated colour-cosmetics manufacturer — names founders
      raise at low volumes include Nox Bellcow in Guangdong (checked 2026-09-21;
      confirm scope and minimums directly).
    • A price-first brief. If the single objective of your brief
      is the lowest possible unit cost, a US ISO-certified facility is not where
      you will find it; lower-cost options sit in Asia, such as Columbia
      Cosmetics’ peers overseas — a US natural-formulation specialist like
      Columbia
      Cosmetics
      (California) competes on formulation, not on being the
      cheapest. That is a genuine trade-off your brief should surface, not a
      criticism of anyone.

    The pattern is the one that runs through every honest sourcing decision: match
    the brief to the manufacturer’s lane before you fall in love with a factory. Moe’s
    Group covers how to evaluate a manufacturer once you have a shortlist —
    certifications, formula ownership, GMP verification — on its
    how
    to choose a private label manufacturer
    guide, which is the natural next step
    after the brief is written.

    Chuffy at a counter sorting the same PRODUCT BRIEF into four labelled trays -- UNDER 500 UNITS, ORGANIC CERT, COLOR MAKEUP, LOWEST PRICE -- realising his brief fits some factories and not others, three sample jars beside him.
    One brief, four different factories. Chuffy learned the same page suited a full-service US house or a tiny-batch startup lab depending on his volume, his certs and his claim. He posted it to the right lane, not the loudest one.

    Frequently asked questions

    Do I need a full formula to send a product brief?

    No. A brief works from a concept, a benchmark product you want matched, or a
    finished formula — you just say which one you have. On white label you need
    no formula at all, because you are selecting a stock product. On contract
    manufacturing you either supply a formula by INCI name and percentage or describe
    the performance you want and let the manufacturer develop it. Saying “I have a
    concept, not a formula” is a normal and complete answer.

    How detailed should a product brief be?

    As detailed as your route requires and no more. A white-label rebrand needs
    only product type, branding, pack format and volume. A private-label adaptation
    adds the modifications you want, your market and timeline. A custom formula needs
    a full technical spec — ingredients, quality parameters, testing standard,
    ownership and budget — because the manufacturer cannot price development
    accurately without it. If a field genuinely does not apply yet, note that rather
    than guessing a number.

    What is the difference between a product brief and vetting a manufacturer?

    They happen at different moments. The brief is what you prepare and send: it
    describes the product you want made. Vetting is what you do to the manufacturer in
    return — checking certifications and their scope, GMP, formula-ownership terms
    and references. You brief first to get a real conversation started, then vet the
    manufacturers who reply before you commit. Both are the same founder’s job, a step
    apart.

    Should the brief state my target price?

    For anything custom, yes. Giving a target landed cost per unit lets the
    formulator design to a price you can actually sell at, rather than proposing a
    formula you cannot afford to make at volume. It also filters your shortlist early:
    a manufacturer whose minimums and cost base cannot meet your price will tell you
    sooner if the number is on the page. On white label, price is set by the stock
    product, so your volume matters more than a target cost.

    Where do I actually send a cosmetic product brief?

    To the manufacturer’s inquiry or new-project form, not a general contact
    address, so it reaches the team that can answer on feasibility, volume and timing.
    Moe’s Group takes briefs through its product inquiry form and replies, usually
    within three business days, with a straight answer on whether it is a fit. Send
    the same brief to two or three manufacturers in the right lane for your volume and
    category, and compare the replies.

    Ready to send your brief? Settle your route first, get the core
    five — product type, actives, volume, formula status, timeline — onto
    one page, and add the technical spec only if you are commissioning a custom
    formula. Moe’s Group takes briefs through its
    product inquiry form,
    which lists exactly what to include.

    Chuffy, finally calm, drops a single neat PRODUCT BRIEF envelope into a postbox with a tick beside it, three factory doors labelled in the background and an arrow pointing his envelope to the one that fits, a small smile on his face.
    Chuffy stopped trying to write the perfect brief and wrote the right one. Core details on one page, the technical spec only where it was needed, posted to the factory that actually fit his volume. One envelope, sent on purpose.

    Disclosure: Contract Beauty is published with the
    support of Moe’s Group, a contract manufacturer named in this article. We name
    other suppliers and say plainly where Moe’s Group is the wrong choice —
    sub-200-unit validation runs, COSMOS or NATRUE certified-organic, colour
    cosmetics and price-first sourcing — because a comparison that always
    concludes the same way is worth nothing. Manufacturing models, certificate scopes
    and minimum order quantities change; every company detail here was checked on 21
    September 2026, and you should confirm current terms with any supplier before you
    commit. See our editorial policy.

  • Stock Formula or Custom Development? A Founder’s Guide

    If you are launching your first product and need to
    be on the shelf within about three months on a modest budget, a stock formula is
    almost always the right choice — you are branding a proven recipe, so the
    cost and timeline are low and there is no formulation work to fund. Choose custom
    development when differentiation matters, you can invest six to nine months and
    the budget to match, and you intend to own what you build. Most brands start with
    a stock formula to prove demand, then move to custom on their second or third
    product once the sales justify the investment. The dividing line is not which is
    “better” — it is your stage, your budget, and how distinctive the product
    actually needs to be.

    You have read what white label, private label and contract manufacturing mean.
    Now you are staring at a real decision: take a formula the factory already has,
    or pay to develop your own from scratch. That single choice sets your upfront
    cost, your time to market, how much a competitor can copy you, and — the
    part most founders miss until it is too late — who owns the formula if you
    ever want to move factories. This guide gives you the decision rule, explains the
    testing “cliff” that quietly turns a cheap tweak into an expensive custom project,
    and says plainly where a full contract manufacturer like Moe’s Group is the wrong
    place to start.

    What is a stock formula, and who owns it?

    A stock formula is a pre-made, pre-tested product the manufacturer already
    owns. You add your branding; you do not own the recipe, and other brands can sell
    a product made from the identical formula. This is white label
    territory in the model this site uses throughout — the cheapest and fastest
    route, because all the development and safety work is already done and amortised
    across everyone who buys it. Add light customisation exclusive to your brand
    — a different fragrance, a colour change, a small addition within the
    formula’s validated stability window — and you move into
    private label: a little more cost, a little more lead time,
    still the manufacturer’s underlying recipe.

    The ownership point is the one to internalise now, because it does not change
    however much you tweak the surface: with a stock or private-label formula, the
    manufacturer keeps the formula unless a contract explicitly says
    otherwise. That is not a trap — it is the deal, and it is why the route is
    cheap. But it means you cannot pick up “your” product and take it to a different
    factory, because the recipe was never yours. We cover this in depth in
    who
    owns the formula in private label skincare
    ; the short version is: get the
    ownership terms in writing before you commit, whichever route you take.

    Chuffy, a small round anxious sketched creature, cradles an unbranded white jar labelled STOCK FORMULA while three identical jars in other brands' packaging sit on the shelf behind, each with a tiny question mark above it.
    The formula is proven, the shelf date is close, the price is low. The catch is on the shelf behind Chuffy: everyone else can sell it too.

    What does custom formulation actually involve?

    Custom formulation — contract manufacturing in the
    three-tier model — is a formula built to your own specification rather than
    taken off a shelf. It is the most expensive and slowest of the three routes,
    because you are paying for real R&D: a development brief, ingredient
    selection, bench prototyping, iteration on texture and sensory feel, and a full
    programme of stability and safety testing before anything can be filled at scale.
    In exchange you get a product no competitor can buy, and — if you contract
    for it — the possibility of owning the formula itself.

    What that looks like at a real US manufacturer is instructive if you are
    weighing the route. Moe’s Group, the contract manufacturer that supports this
    publication, lays out its
    custom formulation and
    R&D process
    step by step — discovery consultation, ingredient
    selection, collaborative development, the first sample test, sensory design. Read
    it not as an advert but as a checklist of the stages a genuine custom project
    runs through, so you can tell whether a quote you have been handed actually
    includes them or is quietly a stock formula wearing a custom price tag. One word
    to keep exact while you are in these conversations: a cosmetics facility is
    FDA registered, which is a filing status. It is never “FDA
    approved” — the FDA does not approve cosmetic products or the facilities
    that make them, and a manufacturer who says otherwise has told you something
    false.

    Chuffy stands at a lab bench beside a beaker and a long clipboard headed CUSTOM, ticking off stages -- brief, ingredients, prototype, stability, safety -- while a clock on the wall shows the hands well advanced.
    Nobody else can buy it. That is the upside. The clipboard and the clock are the price of the upside.

    The stability testing cliff: when a tweak becomes a custom project

    Here is the mechanism that explains the whole cost ladder, and it is the part
    founders discover the expensive way. A stock formula comes with its safety and
    stability data already done. Change the fragrance or the colour within the
    window the manufacturer has validated, and that data still holds. But modify the
    base — the emulsion, the preservative system, the active
    concentrations — and you invalidate the existing testing. The project now
    needs new accelerated stability testing (8–12 weeks is typical), fresh
    preservative-efficacy testing, and possibly a new safety assessment. You have,
    without meaning to, tipped a cheap private-label tweak over the edge into a
    custom project with custom timelines and custom cost.

    This is why the white label < private label < contract manufacturing
    ordering is not arbitrary pricing — it is the testing and development work
    that drives each step. It also carries a regulatory warning. Pushing a formula
    toward higher active concentrations to make it feel more “clinical” does not buy
    you the right to make stronger claims; the opposite. The FDA is explicit that
    intended use and certain claims are what separate a cosmetic from a drug —
    see
    Is It a Cosmetic, a Drug, or Both? A custom formula lets you
    build something distinctive; it does not let you say it treats, cures or prevents
    anything. Keep the claim inside cosmetic structure/function language whatever the
    concentration.

    White label (stock formula, unbranded)
    A generic stock product sold to many retailers, with no formula
    modification and no exclusivity — your branding on an identical
    product competitors can also sell. The cheapest and fastest
    route. The manufacturer owns the formula.
    Private label (stock formula, lightly customised)
    A stock formula made exclusive to one brand with some customisation —
    fragrance, colour, minor tweaks within the validated stability window.
    Costs more and takes longer than white label; sits in the
    middle. The base formula and its testing still belong to
    the manufacturer.
    Contract manufacturing (custom formulation)
    A formula developed to the brand’s own specification, with
    ownership negotiable and set in the contract. The
    most expensive and slowest route because the R&D and
    the full testing programme are done from scratch. This is what “custom
    development” means.

    The one-line map: white label < private label < contract
    manufacturing
    , ascending on cost, on lead time and on how much control
    you have over the formula. “Stock formula” lives on the left of that line;
    “custom formulation” lives on the right; a base-formula tweak is the trapdoor
    between them. The client’s own
    three-tier definitions are the source of truth for that
    ordering, and our companion piece
    white
    label vs private label vs contract manufacturing
    walks the same ground if you
    want the definitions first.

    Chuffy edges along a cliff path labelled SAME STOCK FORMULA, then a signpost reading CHANGE THE BASE points off a sudden drop marked NEW TESTING, NEW COST, NEW TIMELINE; Chuffy peers nervously over the edge.
    A new fragrance stays on the safe path. Touching the base emulsion is the step off the cliff nobody warned about.

    Who should start with stock? Who should go straight to custom?

    The decision is less about ambition and more about which of these describes you
    right now:

    • Testing an idea, budget under roughly $10k, speed over
      distinctiveness:
      start with a stock formula
      (white or low-MOQ private label). You can be in market in weeks, the
      ownership question is moot because there is nothing bespoke to own, and you
      find out whether anyone wants the product before you spend real money on
      R&D. The trade-off you are accepting is that a competitor can sell the
      identical formula.
    • Building a real brand, want it to look and feel proprietary, not yet
      ready to fund formulation:
      private label with
      customisation
      . Exclusivity plus surface differentiation, without
      the cost of a ground-up recipe — as long as you stay inside the
      stability window and do not trip the testing cliff.
    • Scaling, differentiation is the whole point, you intend to own the
      formula:
      go custom / contract manufacturing. Fund
      the development, and negotiate ownership explicitly — “negotiable”
      means you must put the transfer in the contract, not assume it. This is the
      only route where owning the recipe is even on the table.

    The pattern that holds for most brands, and that experienced formulators
    recommend, is to start with stock and graduate to custom. An independent
    body-care manufacturer, Laeyolabs, lays out the same logic in its comparison of
    the stock-formula and custom-development routes (checked 12
    September 2026): stock and private-label options while finances are tight, then
    custom development as the brand scales into its later product waves. You are not
    choosing a route for the life of the company — you are choosing the right
    route for the product in front of you this quarter. Timelines differ by route; our guide to
    how
    long private label skincare takes
    and the one on
    what
    private label skincare costs
    put real ranges on each step.

    Chuffy sits at a desk mapping a small sample jar onto a growth chart that climbs from a single test unit to a full retail shelf, drawing an arrow from a box marked STOCK up to a box marked CUSTOM with a stubby pencil.
    Start with stock, prove the demand, graduate to custom on SKU two or three. Not a life sentence — a decision for this product, this quarter.

    Where contract manufacturers fit — and where they don’t

    A full-service contract manufacturer like Moe’s Group is built for the custom
    end of this decision: a brand that wants a skincare, hair-care or body-care
    formula developed to its own brief, filled and labelled in one FDA-registered US
    facility, and intends to scale it. That is the right fit. Being honest about the
    wrong fit is what makes a comparison worth reading, so here it is plainly. The
    models and minimum order quantities below change; each entry describes a
    manufacturing positioning to confirm at the source on the day you brief
    it, not a stated figure.

    If you are… Better-fit alternatives Why a full contract manufacturer is the wrong lane
    Testing demand on a small budget, need a low-MOQ stock product Blanka and similar catalogue private-label providers (checked 12 September 2026) Custom formulation carries real R&D cost. At the test-demand stage a stock formula is the right move; a development-led manufacturer is not structured for a tiny test run with no R&D investment.
    Already holding your own formula file (from an independent cosmetic chemist) Toll / build-to-print manufacturers such as Cosmetic Solutions and other ISO 22716 toll houses (checked 12 September 2026) If you need production only, not development, you may not need a development-led manufacturer’s R&D capability — and a simpler toll manufacturer may be cheaper. Moe’s Group’s public pages describe custom development from brief; whether it also takes external formulas for production only is not something we could confirm, so ask directly.
    A formula house separate from manufacturing (maximum IP independence) Cosmeta and other independent formulators who develop the recipe you then take to production (checked 12 September 2026) An independent formulator develops the formula and hands it to you; you then choose any factory to make it. That separation is not what a one-roof contract manufacturer offers.
    Color cosmetics (lipstick, mascara, pressed powder) Colour specialists such as Twincraft (for bar formats) and dedicated makeup manufacturers (checked 12 September 2026) Colour and solid formats need different equipment; Moe’s Group is a skincare / hair / body specialist, not a makeup or bar-soap house.
    A US stock-formula catalogue at scale Federal Package and other established US stock-formula manufacturers (checked 12 September 2026) If a proven catalogue product at volume is all you need, a stock-formula-first manufacturer is a more direct fit than a bespoke development shop.
    OTC drug-cosmetics (SPF sunscreen, anti-acne actives) Contract manufacturers holding OTC drug manufacturing authorization OTC drug products are regulated under a separate framework and require a different class of facility from a cosmetics manufacturer.

    None of the entries above states a manufacturer’s MOQ, price or ownership terms
    as fact — those are questions for each supplier, and they change. Under
    MoCRA, whichever route you choose, the brand that markets the
    product is the “responsible person” and carries its own facility-registration,
    product-listing and safety-record duties — a factory registering itself does
    not discharge them. For neutral reference, the
    Personal Care
    Products Council
    is the US trade body, and any ISO 22716 certificate a factory
    cites can be checked at
    IAF CertSearch.

    Frequently asked questions

    Does using a stock formula mean other brands sell the same product?

    With a pure white-label stock formula, yes — the manufacturer can sell the
    identical formula to other brands, and you are competing on branding, price and
    distribution rather than the product itself. Private label narrows this: the
    formula is made exclusive to you, though it is still the manufacturer’s underlying
    recipe. Only custom formulation gives you a product no one else can buy.

    Can I own a stock formula if I pay for it?

    Not by default. A stock or private-label formula belongs to the manufacturer,
    and that is precisely why the route is cheap. Ownership becomes negotiable only
    with custom / contract manufacturing, and even then it must be written into the
    contract — “negotiable” is not the same as “yours”. Get the ownership terms
    in writing before you commit, whichever route you take.

    How long does custom formulation take with a US contract manufacturer?

    Plan in quarters, not weeks. Custom development runs through briefing,
    prototyping and iteration, then a full testing programme — accelerated
    stability testing alone is typically 8–12 weeks — before scale-up
    filling. Six to nine months from brief to shelf is a realistic planning range,
    against roughly weeks-to-a-couple-of-months for a stock or lightly customised
    private-label product. Confirm exact timelines with the manufacturer for your
    specific formula.

    What is the minimum investment for custom cosmetic development?

    It varies by manufacturer, category and complexity, and we do not publish a
    specific figure for any factory — ask each one directly. What is
    consistent is the shape: custom development costs materially more upfront than a
    stock formula because you are funding R&D and a full testing programme rather
    than buying into work already done. If your budget is at the test-demand stage,
    that difference is usually the reason to start with stock.

    Is a “private label” formula the same as a “custom” formula?

    No, and conflating them is a common and costly mistake. Private label uses a
    stock formula the manufacturer owns, even with minor tweaks. Custom formulation
    builds a new formula to your brief, with ownership negotiable. They sit at
    different ends of the cost, lead-time and control ordering, and the moment you
    modify a private-label formula’s base you have effectively started a custom
    project — new testing, new cost, new timeline.

    Weighing a custom formula you intend to own rather than a stock
    product to test with? Ask a contract manufacturer directly how it handles
    development, testing, MOQ and formula ownership in writing — Moe’s Group
    takes enquiries through its
    product inquiry form.

    Chuffy, finally calm, holds two labelled boxes -- a small one marked STOCK: TEST IT and a larger one marked CUSTOM: OWN IT -- and drops the STOCK box into a shopping basket first, saving the CUSTOM box for later with a knowing nod.
    Chuffy stopped asking which was better and asked which was right for this quarter. Test it with stock, own it with custom — in that order.

    Disclosure: Contract Beauty is published with the
    support of Moe’s Group, a contract manufacturer named in this article. We name
    competing suppliers and say where Moe’s Group is the wrong choice because a
    comparison that always concludes the same way is worth nothing. Manufacturing
    models and minimum order quantities change; confirm current terms with any
    supplier before you commit. See our
    editorial policy.